This underscores the importance of specific diagnostic testing in identifying cryptic fusions or rare subsets of CBFB::MYH11 AML that may otherwise be overlooked by morphological, conventional cytogenetic and molecular testing. Here, MYH11 is linked to acute myeloid leukemia.